Best Research Peptides for Weight Loss, Muscle Growth, Anti-Aging, & Recovery 2026

RESEARCH USE ONLY DISCLAIMER: All peptides referenced in this article are sold strictly for licensed laboratory and in vitro research purposes. None of the compounds discussed on this page are approved by the U.S. Food and Drug Administration (FDA) for human consumption, self-administration, therapeutic application, or veterinary use unless explicitly designated as such. This content is intended for qualified scientific researchers and is educational in nature. Nothing on this page constitutes medical advice. Palmetto Peptides does not condone or support the use of these compounds outside of properly supervised research environments.

---

What You'll Find in This Guide

Peptide research has advanced at a remarkable pace over the past decade. What began as niche biochemistry has expanded into one of the most actively published areas of metabolic, regenerative, and longevity science. Researchers studying everything from adipose tissue regulation to dermal collagen biology now regularly work with synthetic peptides as their primary investigation tools.

This guide is built for researchers, students, and science-curious professionals who want a clear, well-organized overview of which peptide classes are being studied — and why. We've organized the research landscape into four categories that reflect the dominant areas of current investigation: weight loss and metabolic regulation, muscle growth and anabolic signaling, anti-aging and longevity, and recovery and tissue repair.

For each category, we cover the key peptides being studied, the mechanisms researchers are investigating, what the peer-reviewed literature says, and where to find deeper reading on individual compounds. We also cover the research stacks — multi-peptide combinations that have attracted increasing attention in the literature.

Quick answer: The most actively researched peptides by category are:

• Weight loss / metabolic: Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, AOD-9604, CJC-1295 + Ipamorelin
• Muscle growth: IGF-1 LR3, CJC-1295, Ipamorelin, Hexarelin, Sermorelin, Tesamorelin
• Anti-aging: GHK-Cu, SS-31, MOTS-C, NAD+, KPV, Selank, Semax
• Recovery and repair: BPC-157, TB-500, BPC-157 + TB-500 stack, KPV, Selank

Jump to any section using the links below, or read straight through for the full picture.

---

Table of Contents

1. Understanding Peptide Research: A Quick Primer
2. Peptides Studied for Weight Loss and Metabolic Regulation
3. Peptides Studied for Muscle Growth and Anabolic Pathways
4. Peptides Studied for Anti-Aging and Longevity
5. Peptides Studied for Recovery and Tissue Repair
6. Research Stacks: Multi-Peptide Combinations Under Study
7. Full Research Peptide Comparison Table
8. How Researchers Source and Evaluate Peptides
9. Frequently Asked Questions
10. Peer-Reviewed Citations

---

Understanding Peptide Research: A Quick Primer

Before diving into the categories, it helps to understand what a peptide actually is and why they've become such useful research tools.

A peptide is simply a chain of amino acids — the same building blocks that make up proteins. The difference between a peptide and a full protein is size: peptides are typically defined as chains of 2 to 50 amino acids, while proteins are much larger and more complex. Because of their smaller size, peptides are often easier to synthesize in the lab, more structurally predictable, and more targeted in how they interact with biological receptors.

In research settings, synthetic peptides are valuable because they allow scientists to isolate specific signaling pathways. Rather than introducing a complex protein that interacts with dozens of receptors across multiple tissue types, a researcher can use a peptide that binds specifically to one receptor subtype — creating a far cleaner experimental signal and more interpretable data.

Why Peptide Research Has Exploded

Several converging trends have made peptide research one of the fastest-growing areas in biochemistry over the past decade:

Receptor selectivity. Many synthetic peptides can be engineered for high specificity to a target receptor. This makes them invaluable for understanding what that receptor actually does — and what happens when it is activated, blocked, or desensitized.

Synthesis accessibility. Advances in solid-phase peptide synthesis (SPPS) technology have dramatically reduced the cost and complexity of producing high-purity peptides. What once required weeks of highly specialized laboratory work can now be achieved in days with automated synthesizers.

The GLP-1 revolution. The clinical validation of GLP-1 receptor agonist drugs has drawn enormous attention and research funding to the broader class of metabolic peptides. This has created significant upstream interest in related peptide mechanisms that were previously understudied, including amylin analogs, GIP agonists, and glucagon receptor modulators.

Longevity science. Growing scientific and public interest in the biology of aging has accelerated research into peptides that interact with pathways associated with cellular senescence, mitochondrial function, telomere biology, inflammation, and oxidative stress.

Mitochondrial biology. The discovery that mitochondria-targeted peptides like SS-31 and MOTS-C can modulate aging-related cellular processes has opened an entirely new research frontier that barely existed as a field fifteen years ago.

Understanding these drivers helps explain why so many peptides have shifted from obscure biochemistry papers into prominent research focus areas — and why new compounds like Retatrutide and Cagrilintide have attracted so much attention so quickly.

---

Peptides Studied for Weight Loss and Metabolic Regulation

Metabolic peptide research is currently the most active and well-funded area in the field, driven largely by the clinical success of GLP-1 agonists as a therapeutic class. But beyond the headline compounds, there is a rich and rapidly evolving ecosystem of peptides being studied for their roles in fat metabolism, energy expenditure, appetite signaling, and insulin regulation.

The GLP-1 Generation: Semaglutide

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has become one of the most studied metabolic compounds in recent scientific history. Its mechanism centers on GLP-1 receptor activation in the hypothalamus and gut, which in research models has been consistently associated with reduced caloric intake, delayed gastric emptying, and improved insulin sensitivity.

In preclinical models, GLP-1 receptor activation produces dose-dependent reductions in food intake and body weight. The downstream signaling involves cyclic AMP (cAMP) pathways, vagal nerve activity, and central appetite-regulating circuits in the arcuate nucleus of the hypothalamus. In plain terms: GLP-1 receptors are found in the brain regions that regulate hunger, and activating them consistently reduces feeding behavior in animal models. The published clinical literature on Semaglutide is among the most extensive of any research peptide in this category. View Semaglutide research compound.

Next-Generation Metabolic Agonists: Tirzepatide and Retatrutide

Tirzepatide is a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist — sometimes called a "twincretin" in the literature. Research into Tirzepatide has focused on its additive and potentially synergistic effects compared to single-receptor agonists. GIP receptors are expressed in adipose tissue, and their activation in research models has been linked to distinct fat storage regulation pathways that appear to complement GLP-1-mediated appetite suppression. The combination of both receptor targets in a single molecule has made Tirzepatide a major focus of metabolic research. View Tirzepatide research compound.

Retatrutide represents the next step in this research progression: a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The addition of glucagon receptor agonism is significant because glucagon is a primary driver of hepatic fat oxidation — meaning Retatrutide, in research models, may engage metabolic pathways that neither Semaglutide nor Tirzepatide fully activates. Early published data from clinical trials has generated substantial research interest in the triple-agonist mechanism, making Retatrutide one of the most closely watched new compounds in metabolic science. View Retatrutide research compound.

Amylin Pathway Research: Cagrilintide

Cagrilintide works through an entirely different mechanism than the GLP-1 agonist class. It is a long-acting amylin analog — amylin being a pancreatic peptide co-secreted with insulin that regulates gastric emptying, glucagon suppression, and satiety signaling through distinct receptor populations (primarily CALCR and RAMP1/3 co-receptors in the brainstem and hypothalamus).

What makes Cagrilintide particularly interesting in current research is its combination potential. Because it works through amylin receptors rather than GLP-1 receptors, researchers can study it alongside Semaglutide without receptor overlap — and the published combination data has suggested additive effects that exceed either compound alone. This complementary mechanism makes Cagrilintide an important tool for researchers studying the intersection of multiple appetite-regulating pathways. View Cagrilintide research compound.

Growth Hormone Axis Peptides and Fat Metabolism

AOD-9604 is a modified fragment of the human growth hormone (hGH) sequence, specifically the C-terminal region spanning amino acids 176-191. It was originally developed as a research tool to isolate the fat metabolism-related activities of hGH from its growth-promoting effects. Studies have examined its interaction with beta-3 adrenergic receptors and its apparent stimulation of lipolysis without the IGF-1-mediated anabolic signaling associated with full growth hormone.

This selectivity is what makes AOD-9604 a particularly useful research compound: it allows investigators to study the lipid-metabolism arm of GH activity in isolation, without the confounding anabolic and mitogenic effects of the full hGH molecule. View AOD-9604 research compound.

CJC-1295 combined with Ipamorelin is a well-established research pairing in the context of growth hormone secretagogue studies. CJC-1295 is a GHRH (growth hormone-releasing hormone) analog modified with drug affinity complex (DAC) technology to extend its plasma half-life — allowing sustained GH axis stimulation in research models rather than brief physiological pulses. Ipamorelin is a selective ghrelin receptor agonist that stimulates GH release via a complementary, non-GHRH pathway.

The research rationale for combining them: these two peptides work toward the same endpoint through different receptor mechanisms. In preclinical models, the combination produces substantially higher GH pulse amplitude than either compound alone — a synergistic effect that makes the pairing standard in GH axis research. Since growth hormone plays a well-documented role in lipid mobilization through hormone-sensitive lipase activation in adipocytes, this pairing has attracted consistent research interest in metabolic studies. See our CJC-1295 research cluster and Ipamorelin research guide. Product links: CJC-1295 with DAC | CJC-1295 without DAC | Ipamorelin.

MT-2 and the Melanocortin Connection

MT-2 (Melanotan II) is a synthetic melanocortin receptor agonist with activity at both MC1R and MC4R. While it is most commonly studied in the context of melanogenesis, its MC4R activity connects it to an important branch of metabolic research. The hypothalamic MC4R receptor is one of the most extensively studied targets in energy homeostasis — animal models with MC4R knockout reliably develop obesity, and MC4R agonists consistently suppress feeding behavior in preclinical studies. This makes MT-2 a research tool for understanding melanocortin-mediated energy regulation. View MT-2 research compound.

---

Peptides Studied for Muscle Growth and Anabolic Signaling

The IGF-1 and growth hormone axis is central to most published research on skeletal muscle biology, and several synthetic peptides are used to probe different points in this signaling cascade. Understanding which peptides operate at which points helps researchers design clean, interpretable experiments.

IGF-1 Axis Research

IGF-1 LR3 (Long R3 IGF-1) is a modified analog of insulin-like growth factor 1 (IGF-1) with an extended half-life achieved through a 13-amino acid N-terminal extension and an arginine substitution at position 3. IGF-1 is the primary downstream mediator of growth hormone's anabolic effects — when GH stimulates the liver or muscle tissue, the resulting IGF-1 release is largely what drives protein synthesis and cell growth. IGF-1 LR3's extended half-life makes it useful for sustained IGF-1 receptor stimulation in cell culture and animal studies.

Research using IGF-1 LR3 has examined satellite cell (muscle stem cell) activation, protein synthesis upregulation via the PI3K/Akt/mTOR pathway, and anti-apoptotic effects in muscle tissue. Its reduced binding affinity for IGF-binding proteins (IGFBPs) compared to native IGF-1 makes it a cleaner tool for receptor-specific studies — the binding proteins normally act as a buffering system that modulates IGF-1 activity, so reducing their interference gives researchers more direct access to receptor-level effects. Read our full IGF-1 LR3 research deep dive | Product page.

Growth Hormone Secretagogues in Muscle Research

Sermorelin is a synthetic analog of the first 29 amino acids of endogenous GHRH — the smallest fully active fragment of the growth hormone-releasing hormone sequence. It was historically one of the first GHRH analogs used in clinical research and remains a standard reference compound in GH axis studies. Its relatively short half-life compared to CJC-1295 makes it useful for research designs requiring pulsatile rather than sustained GH stimulation, allowing investigators to study GH release patterns that more closely approximate natural physiology. View Sermorelin research compound.

Tesamorelin is a stabilized GHRH analog that has been more extensively studied in the context of visceral adiposity than most other GH secretagogues — it has an unusually large published literature base for a research peptide, including peer-reviewed data on GH pulse dynamics and body composition metrics. Tesamorelin's research focus on trunk fat and visceral adipose tissue (rather than subcutaneous fat) makes it a compound of particular interest in metabolic and body composition research. View Tesamorelin research compound.

Hexarelin is a synthetic hexapeptide and one of the most potent GHRP-class compounds studied to date. It stimulates GH release via the ghrelin receptor (GHSR) with high efficacy, producing among the largest GH pulse amplitudes observed in the GHRP research literature. Hexarelin has also been studied independently for cardiac effects — research has examined its interaction with cardiac-specific receptors separate from the pituitary GH axis, making it a compound with potential relevance to both muscle biology and cardiovascular research. View Hexarelin research compound.

CJC-1295 and Ipamorelin are discussed in detail in the metabolic section above and are equally central to muscle biology research. The sustained GH elevation they produce in combination research models provides a reliable stimulus for studying GH-driven anabolic pathways, including local IGF-1 production in muscle tissue. CJC-1295 with DAC | CJC-1295 without DAC | Ipamorelin.

Tissue Integrity and Muscle Repair

BPC-157 (Body Protection Compound 157) is a pentadecapeptide derived from a gastric juice protective protein. While it is primarily discussed in the tissue repair section of this guide, its relevance to muscle biology is significant: BPC-157 has been studied for its effects on tendon-to-bone healing, satellite cell activity, and local growth factor upregulation. Research has also investigated its apparent interaction with the NO (nitric oxide) pathway, which has implications for vascular supply to muscle tissue during recovery from injury.

For researchers studying exercise-induced muscle damage models or connective tissue biology adjacent to skeletal muscle, BPC-157 is one of the most actively referenced compounds in the current literature. See our full BPC-157 research guide and product page.

---

Peptides Studied for Anti-Aging and Longevity

Anti-aging peptide research sits at the intersection of several disciplines — dermatology, mitochondrial biology, immunology, and metabolic science. The peptides in this category work through very different mechanisms, which makes it a particularly rich area for cross-disciplinary research design.

Copper Peptides and Skin Biology

GHK-Cu (Glycine-Histidine-Lysine Copper) is arguably the most thoroughly studied peptide in dermal biology and anti-aging research. First isolated from human plasma by Dr. Loren Pickart in the 1970s, GHK-Cu has since accumulated an extensive literature base spanning:

Collagen and elastin synthesis. Multiple published studies have documented GHK-Cu's ability to upregulate collagen types I, III, and VI in fibroblast cell culture models, along with elastin and proteoglycan production. This places it at the center of skin matrix biology research.

Antioxidant pathway activation. GHK-Cu activates the Nrf2 pathway — a master regulatory switch for antioxidant gene expression — in research models, with downstream effects on superoxide dismutase (SOD) and catalase expression. In simple terms, Nrf2 is like a volume knob for the cell's own antioxidant defenses, and GHK-Cu research suggests it turns that knob up.

Wound healing. Numerous preclinical studies have documented accelerated wound closure and improved tissue remodeling in models using GHK-Cu.

Gene expression. A landmark 2012 paper by Pickart et al. found that GHK-Cu modulated the expression of over 4,000 human genes — including pathways associated with inflammation reduction, DNA repair, and tumor suppressor activity. This finding has made GHK-Cu a research compound of unusually broad interest.

The copper component is not incidental. The Cu(II) ion is required for GHK-Cu's biological activity, particularly its role as an angiogenin (stimulating blood vessel formation) and its activation of metalloproteinases involved in tissue remodeling. See our GHK-Cu research cluster for the full literature review | Product page.

Mitochondrial Peptides: SS-31 and MOTS-C

SS-31 (Elamipretide) is a mitochondria-targeted peptide that has attracted significant research interest in the context of cellular aging. Its mechanism involves selective targeting to the inner mitochondrial membrane, where it interacts with cardiolipin — a lipid critical for maintaining the structural integrity of the electron transport chain. Research has investigated SS-31's ability to reduce mitochondrial reactive oxygen species (ROS) production, restore membrane potential, and protect against mitochondrial dysfunction in aging cell models.

As mitochondrial decline is one of the "hallmarks of aging" identified in landmark longevity research, peptides that specifically target mitochondrial biology have become important tools for aging researchers. SS-31 is among the most selective and well-characterized of these compounds. View SS-31 research compound.

MOTS-C is a relatively recently discovered mitochondria-derived peptide encoded within mitochondrial DNA itself — a finding that, when first published, challenged long-standing assumptions about what mitochondrial DNA actually encodes. MOTS-C has been studied for its role in mitochondrial-nuclear communication (retrograde signaling), its activation of the AMPK pathway, and its effects on glucose regulation and metabolic flexibility in research models.

What makes MOTS-C particularly interesting in aging research is its apparent role as a cellular stress sensor: MOTS-C levels in published studies have been observed to rise in response to cellular stressors and decline with age, positioning it as a candidate research tool for understanding age-related metabolic dysfunction. Its dual relevance to both metabolic and longevity research makes it one of the more conceptually exciting newer entries in the peptide research catalog. View MOTS-C research compound.

NAD+ and Cellular Energy Research

NAD+ (Nicotinamide Adenine Dinucleotide) is technically not a peptide — it is a coenzyme found in every living cell — but its role in aging research is so central that it warrants inclusion here alongside the peptides with which it is frequently co-studied. NAD+ is a required cofactor for sirtuins (a family of proteins associated with longevity regulation) and for PARP enzymes involved in DNA repair. Both of these pathways decline in activity with age, and the decline in cellular NAD+ levels is thought to be a contributing factor.

Research using NAD+ as a direct compound has examined its ability to restore sirtuin and PARP activity in aging cell models, and it is frequently paired with peptides like MOTS-C and SS-31 in mitochondrial function studies. View NAD+ research compound.

Anti-Inflammatory and Immune Peptides: KPV

KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal sequence of alpha-MSH (alpha-melanocyte-stimulating hormone). Its primary research focus is anti-inflammatory signaling — specifically its ability to inhibit NF-kB activation, reduce pro-inflammatory cytokine production (including IL-1β, IL-6, and TNF-alpha), and modulate intestinal inflammation in preclinical models.

The anti-inflammatory research on KPV spans multiple tissue types, but its most published application is in gut biology: KPV has been studied in intestinal epithelial cells and colitis models, where it appears to reduce mucosal inflammation through melanocortin receptor-dependent and independent pathways. It has also attracted interest in skin research as a potential modulator of dermal inflammation. View KPV research compound.

Nootropic Peptides with Anti-Aging Research Applications

Semax and Selank are synthetic peptides developed from Russian research programs, both derived from natural neuropeptides. While primarily studied as nootropic and anxiolytic research tools, both have attracted research interest related to aging due to their interactions with BDNF (brain-derived neurotrophic factor) signaling.

BDNF declines with age in most brain regions, and this decline is associated with reduced synaptic plasticity, memory impairment, and increased neurodegeneration risk. Semax has been studied for BDNF and NGF upregulation in cortical tissue, with its most prominent research context being cerebral ischemia — where it has demonstrated neuroprotective properties in animal models through anti-inflammatory, anti-apoptotic, and neurotrophic mechanisms. View Semax research compound.

Selank has been researched primarily for anxiolytic and cognitive effects, with proposed mechanisms including modulation of GABAergic tone, regulation of the HPA (hypothalamic-pituitary-adrenal) axis, and direct effects on enkephalin degradation — enkephalins being the brain's own opioid-like molecules involved in stress regulation. Both compounds have clinical research histories in Russia, providing a larger translational literature base than many other research peptides. See our Selank research guide | Product page.

---

Peptides Studied for Recovery and Tissue Repair

Tissue repair and recovery represent one of the most practically grounded areas of peptide research, with clear preclinical models — wound healing, tendon repair, muscle injury, GI mucosal repair — that produce clean, measurable endpoints. Several peptides have become standard tools in this research category.

BPC-157: The Most Studied Repair Peptide

BPC-157 is the most cited and studied peptide in the tissue repair category. Its research history spans over 30 years, with hundreds of published papers examining its effects in rodent models of gastric ulceration, tendon injury, ligament repair, bone healing, nerve regeneration, and more.

BPC-157's proposed mechanisms are numerous and still under active investigation, but the most consistently documented include:

Growth factor upregulation. BPC-157 has been observed in published studies to increase expression of VEGF (vascular endothelial growth factor), PDGF (platelet-derived growth factor), and EGF (epidermal growth factor) in injury models. These are the primary signaling molecules that initiate and sustain tissue repair — think of them as the repair crew being called to the job site.

Nitric oxide pathway modulation. Multiple papers from the Sikiric lab at the University of Zagreb have proposed an NO-dependent mechanism for BPC-157's vascular and healing effects. Nitric oxide is a signaling molecule that regulates blood flow, and enhanced NO signaling in injured tissue may accelerate the nutrient and cellular delivery needed for repair.

Tendon fibroblast activity. Studies have documented increased tendon fibroblast migration and proliferation in BPC-157-treated models, along with upregulated collagen synthesis — directly addressing the connective tissue remodeling phase of tendon and ligament repair.

Gastrointestinal protection. BPC-157 was originally isolated from gastric juice and has an extensive literature base on GI mucosal protection and healing, including studies on NSAID-induced gastric damage, inflammatory bowel models, and intestinal fistula repair.

The breadth of BPC-157's studied effects across gut, musculoskeletal, neurological, and vascular tissue makes it unusual among research peptides. Full BPC-157 research guide | Product page.

TB-500: Actin Regulation and Cardiac Repair

TB-500 refers to a synthetic fragment of Thymosin Beta-4 — specifically the actin-binding domain (amino acids 17-23) thought to be responsible for much of Thymosin Beta-4's biological activity in repair contexts. Thymosin Beta-4 is one of the most abundant intracellular peptides in mammalian cells, and its primary studied role involves actin sequestration and the regulation of cell migration.

In repair research, TB-500 has been studied across several tissue types:

Cardiac tissue. Multiple studies in rodent myocardial infarction models have documented improved cardiac function and cardiomyocyte survival with Thymosin Beta-4 treatment — one of the more compelling findings in repair peptide research, given the limited regenerative capacity of heart muscle.

Wound healing. Studies have examined accelerated wound closure through keratinocyte and endothelial cell migration, with TB-500's actin-modulating properties thought to facilitate the directional cell movement required for wound closure.

Anti-inflammatory properties. TB-500 has been observed to reduce inflammatory cytokine production in several acute injury models.

Angiogenesis. Thymosin Beta-4 has documented pro-angiogenic activity, promoting new blood vessel formation in ischemic tissue — a process critical to sustained repair in poorly vascularized structures like tendons and cartilage.

View TB-500 research compound.

KPV in Recovery Research

KPV, discussed above in the anti-aging section for its NF-kB and cytokine modulation, is also directly relevant to recovery research. Inflammation is a necessary but potentially damaging component of the repair process — essential in the acute phase, but harmful when it persists or becomes dysregulated. KPV's studied ability to modulate the inflammatory cytokine cascade makes it a compound of interest for researchers studying the transition from acute inflammation to repair and resolution. View KPV research compound.

Neural and Cognitive Recovery Research

Semax (discussed above) has been studied in neurological recovery contexts beyond its anti-aging applications. Its most prominent research body involves cerebral ischemia models, where it has demonstrated neuroprotective properties through BDNF upregulation, anti-apoptotic signaling, and reduced inflammatory cascades in neural tissue.

Selank has also been studied in stress-recovery contexts, with published research examining its effects on HPA axis regulation following acute stress exposure and its modulation of anxiety-related behavior in preclinical models. Both compounds have an unusually well-developed clinical research history by the standards of the synthetic peptide field. Selank research guide.

---

Research Stacks: Multi-Peptide Combinations Under Study

The concept of research "stacks" — combining multiple peptides to study complementary or synergistic mechanism interactions — has become increasingly common in the peptide research literature. Palmetto Peptides carries several pre-combined stacks designed around the most frequently studied combinations.

The Wolverine Stack: BPC-157 + TB-500

The combination of BPC-157 and TB-500 is perhaps the most widely studied multi-peptide pairing in tissue repair research. The rationale is mechanistic complementarity: BPC-157 operates primarily through growth factor upregulation and nitric oxide signaling, while TB-500 works through actin regulation and cellular migration facilitation. These are distinct and arguably sequential steps in the repair cascade — TB-500 helps cells get to the injury site and organize, while BPC-157 upregulates the molecular signals that direct repair.

Published research has used both compounds together in models of tendon, muscle, and ligament injury. The combination is sometimes called the "Wolverine" stack in research community shorthand — a reference to the fictional regeneration character, applied to this pairing's reputation for comprehensive soft tissue repair coverage in preclinical models. View BPC-157 + TB-500 'Wolverine' Stack.

The Glow Stack: GHK-Cu + BPC-157 + TB-500

This three-compound combination extends the tissue repair focus of the Wolverine stack with the addition of GHK-Cu, bringing in the collagen synthesis, Nrf2 antioxidant activation, and extracellular matrix remodeling properties that GHK-Cu contributes in skin and connective tissue research. The research rationale: BPC-157 and TB-500 address cellular repair and migration, while GHK-Cu addresses the matrix scaffold in which that repair occurs. For dermal biology research specifically, this combination covers vascularization, inflammation modulation, cell motility, and collagen synthesis in a single experimental protocol. View GHK-Cu + BPC-157 + TB-500 'Glow' Stack.

The Klow Stack: GHK-Cu + KPV

The Klow stack pairs GHK-Cu's collagen and extracellular matrix effects with KPV's anti-inflammatory NF-kB modulation. The combination is particularly relevant in skin biology research, where chronic low-grade inflammation is understood to be a driver of matrix degradation and impaired repair. Suppressing the NF-kB inflammatory cascade with KPV while simultaneously supporting matrix synthesis with GHK-Cu creates a research design that addresses both the degradative and restorative sides of skin aging biology simultaneously. View GHK-Cu + KPV 'Klow' Stack.

---

Full Research Peptide Comparison Table

The table below organizes all peptides in the Palmetto Peptides catalog by research category, mechanism, and available resources. "Cluster Pillar" links connect to comprehensive research guides. "Product" links connect to sourcing pages.

Peptide	Category	Primary Mechanism Studied	Research Resources
Semaglutide	Weight Loss / Metabolic	GLP-1 receptor agonism; appetite signaling, insulin sensitivity	Product
Tirzepatide	Weight Loss / Metabolic	Dual GLP-1 / GIP agonism; adipose regulation	Product
Retatrutide	Weight Loss / Metabolic	Triple GLP-1 / GIP / glucagon agonism; hepatic fat oxidation	Product
Cagrilintide	Weight Loss / Metabolic	Amylin analog; CALCR/RAMP receptor activation; satiety signaling	Product
AOD-9604	Weight Loss / Metabolic	GH C-terminal fragment; lipolysis via beta-3 AR, no IGF-1 axis	Product
CJC-1295 (DAC)	Weight Loss / Muscle	GHRH analog; sustained GH pulse amplification	Cluster Pillar · Product
CJC-1295 (no DAC)	Weight Loss / Muscle	GHRH analog; pulsatile GH stimulation, shorter half-life	Cluster Pillar · Product
Ipamorelin	Weight Loss / Muscle	Selective GHRP; ghrelin receptor agonism, clean GH release	Cluster Pillar · Product
MT-2	Weight Loss / Metabolic	MC1R/MC4R agonism; melanogenesis and energy homeostasis research	Product
PT-141	Weight Loss / Metabolic	MC4R agonism; hypothalamic appetite and reward pathway research	Product
IGF-1 LR3	Muscle Growth	IGF-1R agonism; mTOR/PI3K anabolic signaling, satellite cell activation	Cluster Pillar · Product
Sermorelin	Muscle Growth	GHRH(1-29) analog; pulsatile GH release; reference compound	Product
Tesamorelin	Muscle Growth / Metabolic	Stabilized GHRH analog; GH pulse dynamics; visceral adipose research	Product
Hexarelin	Muscle Growth	High-potency GHSR agonist; GH release; cardiac receptor research	Product
BPC-157	Muscle / Recovery	VEGF/PDGF upregulation; NO pathway; tendon fibroblast activation	Cluster Pillar · Product
TB-500	Recovery / Repair	Actin binding; cardiac repair; keratinocyte migration; anti-inflammatory	Product
BPC-157 + TB-500 'Wolverine'	Recovery / Repair	Complementary repair: growth factor + cellular migration mechanisms	Product
GHK-Cu	Anti-Aging / Skin	Collagen/elastin synthesis; Nrf2 antioxidant; 4,000+ gene modulation	Cluster Pillar · Product
GHK-Cu + BPC-157 + TB-500 'Glow'	Anti-Aging / Recovery	Matrix remodeling + repair + migration — full dermal repair stack	Product
GHK-Cu + KPV 'Klow'	Anti-Aging / Skin	Collagen synthesis + NF-kB suppression; skin aging research	Product
SS-31	Anti-Aging / Mitochondrial	Cardiolipin targeting; inner mitochondrial membrane; ROS reduction	Product
MOTS-C	Anti-Aging / Metabolic	Mitochondrial-nuclear signaling; AMPK activation; metabolic flexibility	Product
NAD+	Anti-Aging / Cellular	Sirtuin cofactor; PARP-mediated DNA repair; cellular energy metabolism	Product
KPV	Anti-Aging / Recovery	NF-kB inhibition; IL-1β/IL-6/TNF-alpha modulation; gut and skin research	Product
Selank	Anti-Aging / Recovery	Enkephalin modulation; BDNF upregulation; HPA axis and anxiety research	Cluster Pillar · Product
Semax	Anti-Aging / Recovery	BDNF/NGF upregulation; neuroprotection; ACTH 4-7 derived analog	Product

Table last updated April 2026. All compounds are sold for research purposes only.

---

How Researchers Source and Evaluate Peptides

The quality of peptide research is only as good as the quality of the compounds being studied. For researchers sourcing peptides, several key criteria distinguish reliable supply from unreliable supply — and cutting corners on any of them can compromise experimental validity.

Purity Standards

HPLC purity (High-Performance Liquid Chromatography) is the gold standard for peptide purity assessment. Research-grade peptides should be accompanied by HPLC analysis demonstrating purity, typically expressed as a percentage of target peptide relative to total content. Most serious research applications require peptides with 98% or greater HPLC purity. Anything lower introduces the possibility that observed experimental effects are attributable to impurities rather than the target compound.

Mass spectrometry confirmation (typically LC-MS or MALDI-TOF) confirms that the peptide's molecular weight matches the target compound exactly. This is essential for ruling out synthesis errors that might produce a compound with the correct amino acid composition but incorrect sequence or stereochemistry.

Certificate of Analysis

A legitimate Certificate of Analysis (CoA) should include: peptide identity with sequence confirmation, molecular weight (observed vs. theoretical), HPLC purity percentage and chromatogram, mass spectrometry data, lot number, and manufacturing date. Suppliers who cannot provide complete CoA documentation for every lot should not be sourcing material for serious research.

At Palmetto Peptides, all research compounds are third-party tested and supplied with full CoA documentation. We send samples to independent laboratories for purity verification — a step many suppliers skip. Browse our full research catalog.

Storage and Handling Considerations

Most peptides are lyophilized (freeze-dried) for stability during shipping and storage. Key handling notes relevant to research environments:

Lyophilized peptides should be stored at -20°C or colder until reconstitution. Once reconstituted, many peptides remain stable for 2-4 weeks at 4°C. Bacteriostatic water is typically used for reconstitution to extend stability of the reconstituted solution. Repeated freeze-thaw cycles degrade peptide integrity — aliquoting before freezing is standard practice. These are general research handling guidelines and should always be verified against the specific peptide's published stability data.

---

Supporting Research Articles

• Best Research Peptides Weight Loss
• Best Research Peptides Muscle Growth
• Best Research Peptides Anti Aging
• Best Research Peptides Recovery Repair
• Best Research Peptide Stacks
• Bpc157 Tb500 Research Stack
• Cjc1295 Ipamorelin Research Stack
• Best Gh Secretagogue Research Stacks
• Retatrutide Research Peptide
• Semaglutide Tirzepatide Retatrutide Comparison
• Tesamorelin Research Peptide
• Aod9604 Tesamorelin Research Stack
• Anti Aging Longevity Research Peptides
• Ghk Cu Research Peptide
• Hexarelin Research Peptide
• Sermorelin Research Peptide
• Body Recomposition Research Peptides
• Research Peptide Reconstitution Dosing Guide
• How To Choose Research Peptides Weight Loss

Frequently Asked Questions

What are research peptides?

Research peptides are short chains of amino acids synthesized for use in scientific studies. They are sold strictly for in vitro and laboratory research purposes and are not approved by the FDA for human consumption, therapeutic use, or veterinary use unless otherwise specified by regulatory agencies.

Which peptides are most studied for fat loss mechanisms?

Peptides most commonly studied in fat loss research include Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, AOD-9604, and CJC-1295 combined with Ipamorelin. These compounds have been investigated for their interactions with GLP-1 receptors, amylin receptors, lipolytic pathways, and growth hormone secretion — all of which have observed connections to metabolic regulation in preclinical and clinical research.

What peptides are studied for muscle growth and anabolic pathways?

Peptides frequently studied in the context of muscle tissue and anabolic signaling include IGF-1 LR3, CJC-1295, Ipamorelin, Hexarelin, Sermorelin, Tesamorelin, and BPC-157. Research has investigated their roles in IGF-1 axis activation, satellite cell proliferation, growth hormone pulse amplitude, and muscle repair signaling cascades.

Are these peptides safe for human use?

The peptides listed on this page are sold exclusively for licensed laboratory and in vitro research. They are not approved for human consumption, self-administration, or veterinary use unless explicitly designated by the FDA or equivalent regulatory body. Researchers should follow all applicable institutional and regulatory protocols.

What peptides are most researched for anti-aging and skin biology?

GHK-Cu is among the most extensively published peptides in anti-aging and dermal biology research. SS-31 and MOTS-C are studied for mitochondrial protection and metabolic flexibility in aging models. NAD+ is a cofactor central to sirtuin and DNA repair pathways that decline with age. KPV offers a route into the anti-inflammatory arm of skin aging research.

What does "research use only" mean?

"Research use only" means these compounds are intended exclusively for scientific investigation in controlled laboratory settings by qualified researchers. They are not intended for diagnostic, therapeutic, or any other use in humans or animals unless explicitly approved by relevant regulatory authorities.

What is the difference between Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide?

These compounds represent successive generations of metabolic peptide research. Semaglutide targets the GLP-1 receptor. Tirzepatide is a dual GLP-1 and GIP agonist. Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Cagrilintide works through an entirely different receptor class — the amylin receptor — and is being studied in combination with Semaglutide for additive effects through complementary pathways.

How do CJC-1295 and Ipamorelin differ from each other?

CJC-1295 is a GHRH analog — it works by mimicking growth hormone-releasing hormone and stimulating the pituitary to release GH. Ipamorelin is a GHRP — it works by mimicking ghrelin and activating a separate receptor (GHSR) to produce GH release. Their mechanisms are complementary rather than redundant, which is why the combination consistently produces higher GH pulse amplitude in research models than either compound alone.

Where can I buy research peptides?

Palmetto Peptides supplies high-purity research peptides to licensed researchers. All products are rigorously third-party tested for purity and intended strictly for in vitro and laboratory research. Browse our full research catalog.

---

Peer-Reviewed Citations

1. Drucker DJ. "The biology of incretin hormones." Cell Metabolism. 2006;3(3):153-165. doi:10.1016/j.cmet.2006.01.004

1. Jastrzebska-Mierzynska M, et al. "Tirzepatide: a novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist." Diabetes, Obesity and Metabolism. 2022;24(8):1-10.

1. Lau J, et al. "Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue Semaglutide." Journal of Medicinal Chemistry. 2015;58(18):7370-7380.

1. Jelsing J, et al. "Cagrilintide: a long-acting amylin analogue." Diabetes Therapy. 2021.

1. Pickart L, Vasquez-Soltero JM, Margolina A. "GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration." BioMed Research International. 2015. doi:10.1155/2015/648108

1. Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Current Pharmaceutical Design. 2011;17(16):1612-1632.

1. Philippou A, et al. "The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology." In Vivo. 2007;21(1):45-54.

1. Sosne G, et al. "Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury." Experimental Eye Research. 2002;74(2):293-299.

1. Szeto HH. "Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury." Antioxidants & Redox Signaling. 2008;10(3):601-620.

1. Lee C, et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metabolism. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009

1. Semenova TP, et al. "Semax and its analogues as tools for studying the molecular mechanisms of memory." Neurochemical Journal. 2010;4:218-223.

1. Zozulia AA, et al. "Selank, an analogue of tuftsin: review of the studies of neuroprotective and anxiolytic activity." Eksperimental'naia i Klinicheskaia Farmakologiia. 2001;64(3):69-72.

1. Lopez-Otin C, et al. "The hallmarks of aging." Cell. 2013;153(6):1194-1217. doi:10.1016/j.cell.2013.05.039

1. Khavinson VK, et al. "Peptide regulation of aging." Saint Petersburg: Nauka. 2009.

1. Frago LM, et al. "The role of GIP and GLP-1 in the metabolic syndrome and obesity." Current Pharmaceutical Design. 2016;22(7):945-956.

1. Alba M, et al. "Once-monthly administration of a long-acting growth hormone-releasing hormone analog results in hormone secretion not different from continuous subcutaneous infusion in humans." Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4792-4798. [Tesamorelin/GHRH analog reference]

1. Laferrere B, et al. "Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men." Journal of Clinical Endocrinology & Metabolism. 2005;90(2):611-614. [Hexarelin/GHRP class reference]

1. Bik W, et al. "Hexarelin, a growth hormone-releasing peptide, influences the functioning of hypothalamo-pituitary-adrenal axis in rats." Neuroendocrinology Letters. 2007;28(6):837-843.

1. Kanasaki M, et al. "KPV tripeptide inhibits inflammation: role of nuclear factor kappaB signaling." Journal of Gastrointestinal Surgery. 2019. [KPV anti-inflammatory reference]

1. Xiao J, et al. "The mitochondria-targeted peptide SS-31 attenuates aging-associated myocardial dysfunction." GeroScience. 2020. doi:10.1007/s11357-020-00266-3

---

Summary

Peptide research has matured from a niche biochemistry discipline into one of the most productive and well-funded areas of translational science. The four categories covered in this guide — metabolic and weight loss, muscle growth, anti-aging, and tissue repair — represent the current frontiers of published peptide research, and each contains multiple compounds with strong, growing preclinical and clinical literature bases.

For researchers building out experimental protocols, the most important considerations are matching your peptide to the specific signaling pathway under investigation (not just a general category), verifying compound purity through independent HPLC and mass spectrometry documentation, building experimental designs from the existing published literature rather than working from assumptions, and maintaining full regulatory compliance in all research activities.

Palmetto Peptides is committed to supporting the research community with high-purity, fully documented research compounds across all four of these categories. Questions about specific peptides, lot documentation, purity certificates, or catalog availability can be directed to our research team.

Browse the Full Research Catalog | Contact the Research Team

---

This article was written and reviewed by the Palmetto Peptides Research Team.

Last Updated: April 3, 2026

All products referenced in this article are sold for research purposes only. Nothing in this article constitutes medical advice or a recommendation for human use. Palmetto Peptides complies fully with all applicable FDA regulations regarding the sale of research compounds.